LOGIN OR REGISTER
Course Library

HIV CARE & TREATMENT: ALL THINGS CONSIDERED - Miami FL

Infectious Diseases
Curriculum:
HIV CARE & TREATMENT: ALL THINGS CONSIDERED
Credits:
2 ANCC Contact Hours 2 AMA PRA Category 1 Credit(s) ™
Launch Date:
June 24, 2014
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, and all interested health care providers involved in the treatment of patients with HIV.

Relevant Terms:

The New Guidelines And The Emergence Of New Agents, Best Practices In The Treatment Of HIV-infected Persons, Conifections, Comorbidities, Initiation Of Treatment, Resistance And Retention.

David A. Wohl, MD

David A. Wohl, MD
Associate Professor of Medicine
University of North Carolina School of Medicine
Site Leader, UNC AIDS Clinical Trials Unit at Chapel Hill
Co-Director, HIV Services for the North Carolina Department of Corrections
Chapel Hill, NC

David Alain Wohl, MD is an Associate Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina (UNC).  He is Site Leader of the UNC AIDS Clinical Trials Unit at Chapel Hill and Co-Directs HIV Services for the North Carolina Department of Correction.  In 2011, Dr. Wohl also became Director of the North Carolina AIDS Education and Training Center (NAETC). 
Dr. Wohl's research aims to optimize the treatment of HIV including identification of most effective therapeutic approaches and minimizing adverse effects of therapy.  He also is active in investigations focused on the nexus between incarceration and the HIV epidemic.  He has chaired several related AIDS Clinical Trials Group (ACTG) and independent studies and receives NIH funding for his corrections related research.
Dr. Wohl serves as a member of the Department of Health and Human Services (DHHS) HIV treatment guidelines panel. In addition to his research and administrative activities, Dr. Wohl maintains a large HIV continuity clinic at UNC and sees patients at the NC state prison.  

​Rafael E. Campo, MD

Rafael E. Campo, MD
Professor of Clinical Medicine         
University of Miami School of Medicine         
Chief Medical Officer         
University of Miami Hospital             
Miami, FL

W. David Hardy, MD

W. David Hardy, MD
Professor of Medicine
David Geffen School of Medicine at UCLA
Director, Division of Infectious Diseases
Cedars-Sinai Medical Center
Los Angeles, CA

W. David Hardy, M.D., is director of infectious diseases at Cedars-Sinai Medical Center in Los Angeles and an associate professor of medicine-in-residence at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). He gained his medical degree from the Baylor College of Medicine in Houston, Texas, in 1981, completed a residency in internal medicine at Harbor-UCLA Medical Center in Torrance, California in 1984 and a clinical fellowship in infectious diseases and immunology in 1986 at UCLA School of Medicine. Later in his career he also completed a postdoctoral fellowship in basic retrovirology in 2002, also at the UCLA School of Medicine. A diplomat of the American Board of Internal Medicine, Dr. Hardy is a member of numerous professional societies including the American Academy of HIV Medicine, for whom he serves as a member of the National Board of Directors and Chairman of the California/Hawaii Chapter. He works with several community organizations, and since 1988 he has been president of the Los Angeles Physicians AIDS Forum, which he co-founded. He has served on the scientific committees for various national and international HIV congresses. 
1. Identify for testing all patients in their practices with an unknown HIV status and those at continued high risk for infection
2. Utilize data and concepts from clinical studies and evidence-based guidelines to initiate treatment in all HIV-infected patients
3. Describe how to incorporate new research data and evidence-based guideline recommendations into clinical practice to minimize adverse events and achieve and maintain maximal viral suppression with ART in all HIV-infected patients
4. Implement treatment strategies based on clinical data and expert recommendations to treat HIV-infected patients with comorbidities and coinfections

Tuesday, June 24, 2014
EPIC | A Kimpton Hotel
Miami, FL
 
Target Audience
The educational design of this activity addresses the needs of physicians, physician assistants, nurse practitioners, registered nurses, and all interested health care providers involved in the treatment of patients with HIV.

Program Overview
Advances in research and an expansion of antiretroviral therapy (ART) options now enable HIV-infected persons to live near-normal lifespans. However, deficits in quality HIV care from treatment initiation throughout long-term retention persist across the spectrum of care. HIV-infected patients can present significant treatment challenges to health care providers with respect to the initiation of treatment, retention, resistance, coinfections, and comorbidities. The recent approval and anticipated arrival of new agents and new combinations, for both treatment-naive and treatment-experienced patients, as well as newly released HIV professional treatment guidelines, highlight the need for continuing medical education (CME). This CME activity presents best practices in the treatment of HIV-infected persons based on the new guidelines and the emergence of new agents to assist you in making informed care and treatment decisions. In addition, it will provide you with the opportunity to immediately put this new knowledge into virtual clinical practice.


Agenda
7:00 PM – 7:05 PM              Welcome and Introduction
7:05 PM – 7:45 PM              Overview of Best Practices in HIV Management and Care
7:45 PM – 7:55 PM             Question-and-Answer Session
7:55 PM – 8:45 PM              Interactive Case Studies
8:45 PM – 9:00 PM              Post Program Evaluation


Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group (Global) and HealthmattersCME. Global is accredited by the ACCME to provide continuing medical education for physicians..
 
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's COA.
 
This educational activity for 2 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
 
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
 
For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com
 
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and HealthmattersCME do not recommend the use of any agent outside of the labeled indications. 
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter
Reported Financial Relationship
Rafael E. Campo, MD
Consultant/Independent Contractor: Gilead Sciences, Inc.; Merck
Grant/Research Support: Gilead Sciences, Inc.; Merck
Stock Shareholder: Abbott; AbbVie
Other: Spouse is employee an stockholder of Merck
W. David Hardy, MD
Consultant/Independent Contractor: Boehringer Ingelheim, Bristol-Myers Squibb, Calimmune, Gilead Sciences, Inc., Janssen, ViiV Healthcare
Grant/Research Support (To Cedars-Sinai Medical Center): Bionor, Gilead, ViiV Healthcare, Vertex
Honoraria: Boerhinger Ingelheim, Bristol-Myers Squibb, Calimmune, Gilead, Janssen, ViiV Healthcare
Speaker’s Bureau: ViiV Healthcare
Stock Shareholder: Merck
David Wohl, MD
Grant/Research Support: Gilead Sciences, Inc.; Merck;  Viiv Healthcare
Honoraria: Gilead Sciences, Inc.;  Janssen
 
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Planner or Manager Reported Financial Relationship
Andrea Funk Nothing to disclose
Amanda Glazar, PhD Nothing to disclose
Stacey Hansen Nothing to disclose
Ashley Marostica, RN, MSN Nothing to disclose
James Murphy Nothing to disclose


                            
This activity is jointly sponsored by Global Education Group and HealthmattersCME.
This activity is co-provided by Global Education Group and HealthmattersCME.
 

This activity is supported by an independent educational grant from Gilead Sciences
Medical Affairs.


COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above

For video playback, install the latest version of Flash or Quicktime.		 Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above



 

Schedule an event with a Standardized Patient
×